The tumor-released EVs induce neutrophil migration toward the tumor microenvironment through the chemokine receptor CXCR2/CXCL8 (IL8) axis, activating the PI3K-AKT pathway in the neutrophils. Here, CXCR2 is linked to neoplasm.